Replies to post #2223 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s pro forma cash @6/30/22=$329.4M—a decrease of $23.9M since 3/31/22 (#msg-168831159).

The $329.4 figure above consists of: $290.0M of net current assets on the 6/30/22 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001177648/000095017022015515/enta-20220630.htm#consolidated_balance_sheets ); and $39.4M of marketable securities on the 6/30/22 balance sheet designated as long-term (e.g. bonds with a time to maturity greater than one year).

Note: Net current assets on the 6/30/22 balance sheet include the $28.7M receivable from the IRS (#msg-169620450).